Found: 61
Select item for more details and to access through your institution.
Similar Limited Protection Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Infection in Vaccinated Individuals With HIV and Comparable Controls.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 7, p. 1, doi. 10.1093/ofid/ofae380
- By:
- Publication type:
- Article
A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07590-w
- By:
- Publication type:
- Article
SARS‐CoV‐2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRs.
- Published in:
- European Journal of Immunology, 2022, v. 52, n. 4, p. 646, doi. 10.1002/eji.202149656
- By:
- Publication type:
- Article
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34961-8
- By:
- Publication type:
- Article
Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33899-1
- By:
- Publication type:
- Article
Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 8, p. 1, doi. 10.1371/journal.ppat.1012453
- By:
- Publication type:
- Article
Comparison of SARS-CoV-2-Specific Antibodies in Human Milk after mRNA-Based COVID-19 Vaccination and Infection.
- Published in:
- Vaccines, 2021, v. 9, n. 12, p. 1475, doi. 10.3390/vaccines9121475
- By:
- Publication type:
- Article
Influenza A Virus Hemagglutinin Trimer, Head and Stem Proteins Identify and Quantify Different Hemagglutinin-Specific B Cell Subsets in Humans.
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 717, doi. 10.3390/vaccines9070717
- By:
- Publication type:
- Article
Primary antibody response after influenza virus infection is first dominated by low-mutated HA-stem antibodies followed by higher-mutated HA-head antibodies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1026951
- By:
- Publication type:
- Article
Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.893648
- By:
- Publication type:
- Article
Editorial: Novel Concepts in Using Broadly Neutralizing Antibodies for HIV-1 Treatment and Prevention.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies.
- Published in:
- EMBO Journal, 2024, v. 43, n. 7, p. 1135, doi. 10.1038/s44318-024-00061-0
- By:
- Publication type:
- Article
Infection and transmission of SARS‐CoV‐2 depend on heparan sulfate proteoglycans.
- Published in:
- EMBO Journal, 2021, v. 40, n. 20, p. 1, doi. 10.15252/embj.2020106765
- By:
- Publication type:
- Article
Atypical Antibody Dynamics During Human Coronavirus HKU1 Infections.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.853410
- By:
- Publication type:
- Article
Signatures of V<sub>H</sub>1-69-derived hepatitis C virus neutralizing antibody precursors defined by binding to envelope glycoproteins.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39690-0
- By:
- Publication type:
- Article
HIV-1 Envelope Glycoprotein Resistance to Monoclonal Antibody 2G12 Is Subject-Specific and Context-Dependent in Macaques and Humans.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0075277
- By:
- Publication type:
- Article
Genome-Wide Association Study on the Development of Cross-Reactive Neutralizing Antibodies in HIV-1 Infected Individuals.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0054684
- By:
- Publication type:
- Article
Cross-Reactive Neutralizing Humoral Immunity Does Not Protect from HIV Type 1 Disease Progression.
- Published in:
- Journal of Infectious Diseases, 2010, v. 201, n. 7, p. 1045, doi. 10.1086/651144
- By:
- Publication type:
- Article
Systematic evaluation of B-cell clonal family inference approaches.
- Published in:
- BMC Immunology, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12865-024-00600-8
- By:
- Publication type:
- Article
Systematic evaluation of B-cell clonal family inference approaches.
- Published in:
- BMC Immunology, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12865-024-00600-8
- By:
- Publication type:
- Article
Distinct spatial arrangements of ACE2 and TMPRSS2 expression in Syrian hamster lung lobes dictates SARS-CoV-2 infection patterns.
- Published in:
- PLoS Pathogens, 2022, v. 18, n. 3, p. 1, doi. 10.1371/journal.ppat.1010340
- By:
- Publication type:
- Article
Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 8, p. 1, doi. 10.1371/journal.ppat.1009736
- By:
- Publication type:
- Article
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 2, p. 1, doi. 10.1371/journal.ppat.1009257
- By:
- Publication type:
- Article
Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics.
- Published in:
- PLoS Pathogens, 2019, v. 15, n. 7, p. 1, doi. 10.1371/journal.ppat.1007920
- By:
- Publication type:
- Article
Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques.
- Published in:
- PLoS Pathogens, 2018, v. 14, n. 2, p. 1, doi. 10.1371/journal.ppat.1006913
- By:
- Publication type:
- Article
From affinity selection to kinetic selection in Germinal Centre modelling.
- Published in:
- PLoS Computational Biology, 2022, v. 18, n. 6, p. 1, doi. 10.1371/journal.pcbi.1010168
- By:
- Publication type:
- Article
Human milk inhibits some enveloped virus infections, including SARS-CoV-2, in an intestinal model.
- Published in:
- Life Science Alliance, 2022, v. 5, n. 12, p. 1, doi. 10.26508/lsa.202201432
- By:
- Publication type:
- Article
Assessing immunogenicity barriers of the HIV-1 envelope trimer.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00746-3
- By:
- Publication type:
- Article
Vaccine-induced neutralizing antibody responses to seasonal influenza virus H1N1 strains are not enhanced during subsequent pandemic H1N1 infection.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1256094
- By:
- Publication type:
- Article
Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 01, doi. 10.3389/fimmu.2023.1147953
- By:
- Publication type:
- Article
Human Milk Antibody Response After Combining Two Different COVID-19 Vaccines: Mix-and-Match.
- Published in:
- Journal of Human Lactation, 2022, v. 38, n. 3, p. 401, doi. 10.1177/08903344221103260
- By:
- Publication type:
- Article
Human Milk Antibodies Against SARS-CoV-2: A Longitudinal Follow-Up Study.
- Published in:
- Journal of Human Lactation, 2021, v. 37, n. 3, p. 485, doi. 10.1177/08903344211030171
- By:
- Publication type:
- Article
Antibodies Against SARS-CoV-2 in Human Milk: Milk Conversion Rates in the Netherlands.
- Published in:
- Journal of Human Lactation, 2021, v. 37, n. 3, p. 469, doi. 10.1177/08903344211018185
- By:
- Publication type:
- Article
The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination.
- Published in:
- Journal of Human Lactation, 2021, v. 37, n. 3, p. 477, doi. 10.1177/08903344211027112
- By:
- Publication type:
- Article
HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth.
- Published in:
- Retrovirology, 2018, v. 15, n. 1, p. N.PAG, doi. 10.1186/s12977-018-0457-7
- By:
- Publication type:
- Article
Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study.
- Published in:
- PLoS Medicine, 2022, v. 19, n. 5, p. 1, doi. 10.1371/journal.pmed.1003991
- By:
- Publication type:
- Article
Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-06659-8
- By:
- Publication type:
- Article
SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients.
- Published in:
- Science Immunology, 2021, v. 6, n. 59, p. 1, doi. 10.1126/sciimmunol.abj1750
- By:
- Publication type:
- Article
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 373, p. 1, doi. 10.1126/scitranslmed.aal2144
- By:
- Publication type:
- Article
The Impact of First-Time SARS-CoV-2 Infection on Human Anelloviruses.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 1, p. 99, doi. 10.3390/v16010099
- By:
- Publication type:
- Article
Lower Broadly Neutralizing Antibody Responses in Female Versus Male HIV-1 Infected Injecting Drug Users.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 4, p. 384, doi. 10.3390/v11040384
- By:
- Publication type:
- Article
Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity.
- Published in:
- Journal of Clinical Immunology, 2023, v. 43, n. 6, p. 1104, doi. 10.1007/s10875-023-01514-7
- By:
- Publication type:
- Article
Evolution of Coronavirus Disease 2019 (COVID-19) Symptoms During the First 12 Months After Illness Onset.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e482, doi. 10.1093/cid/ciab759
- By:
- Publication type:
- Article
Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 8, p. 1, doi. 10.1371/journal.ppat.1005110
- By:
- Publication type:
- Article
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies.
- Published in:
- PLoS Pathogens, 2013, v. 9, n. 9, p. 1, doi. 10.1371/journal.ppat.1003618
- By:
- Publication type:
- Article
Precision-Cut Liver Slices as a New Model to Study Toxicity-Induced Hepatic Stellate Cell Activation in a Physiologic Milieu.
- Published in:
- Toxicological Sciences, 2005, v. 85, n. 1, p. 632, doi. 10.1093/toxsci/kfi127
- By:
- Publication type:
- Article
Comparing Human Milk Antibody Response After 4 Different Vaccines for COVID-19.
- Published in:
- JAMA Pediatrics, 2022, v. 176, n. 6, p. 611, doi. 10.1001/jamapediatrics.2022.0084
- By:
- Publication type:
- Article
Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010.
- Published in:
- 2011
- By:
- Publication type:
- research
Correction: Rational design of HIV vaccine andmicrobicides: report of the EUROPRISE annualconference.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice
Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference.
- Published in:
- Journal of Translational Medicine, 2010, v. 8, p. 72, doi. 10.1186/1479-5876-8-72
- By:
- Publication type:
- Article